145
Participants
Start Date
August 1, 2018
Primary Completion Date
May 24, 2020
Study Completion Date
August 9, 2022
Loncastuximab tesirine
intravenous infusion
Anastasios Stathis, Bellinzona
North Shore Hematology Oncology Associates DBA NY Cancer and Blood Specialists, East Setauket
A.O. SS Antonio e Biagio e Cesare Arrigo, Alessandria
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
U.O. Oncologia ed Ematologia, Rozzano
Dipartimento di Oncomatlolgia - Unita Linfomi, Milan
Divisione di Oncoematologia, Milan
Virginia Cancer Specialists, PC, Fairfax
Hollings Cancer Center, Charleston
GHD Cancer Institute, Greenville
Northwest Georgia Oncology Centers, PC-Drug Shipment, Lab and Study Supplies Only, Marietta
Winship Cancer Institute of Emory University, Atlanta
Northside Hospital, Atlanta
University of Miami Hospital and Clinics, Miami
Miami Cancer Institute, Miami
Istituto di Ematologia Seragnoli, Bologna
University Hospitals Cleveland Medical Center, Cleveland
Medical Oncology & Hematology Associates, Des Moines
Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Washington University School of Medicine, St Louis
University of Nebraska Medical Center/ Nebraska Medicine, Omaha
Ochsner Clinic Foundation, New Orleans
Baylor University Medical Center, Dallas
Baylor Scott & White Medical Center - Temple, Temple
The Oncology Institute of Hope and Innovation, Whittier
City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
UC San Diego Moores Cancer Center, La Jolla
Compassionate Care Research Group, Inc., at Compassionate Care Medical Group, Inc., Fountain Valley
University of California, San Francisco Medical Center, San Francisco
Vista Oncology Inc. PS, Olympia
University Hospitals of Leicester NHS Trust., Leicester
University College London Hospital, London
The Christie NHS Foundation Trust, Manchester
Oxford Cancer Centre, Churchill Hospital, Oxford
NHS Greater Glasgow and Clyde, Glasgow
Abertawe Bro Morgannwg University Health Board - Singleton Hospital, Swansea
Nottingham University Hospitals NHS Trust, Nottingham
Lead Sponsor
ADC Therapeutics S.A.
INDUSTRY